Skip to main content
Top
Published in: Diseases of the Colon & Rectum 5/2007

01-05-2007

Patient Preferences Between Surgical and Medical Treatment in Crohn’s Disease

Authors: Christopher M. Byrne, M.B.B.S., B.Sc.(Med.), M.S., F.R.A.C.S., Michael J. Solomon, M.B.B.Ch.(Hons.), M.Sc., F.R.A.C.S., Jane M. Young, M.B.B.S., M.P.H., Ph.D., F.A.F.P.H.M., Warwick Selby, M.B.B.S., F.R.A.C.P., James D. Harrison, B.Sc.(Hons.), M.P.H.

Published in: Diseases of the Colon & Rectum | Issue 5/2007

Login to get access

Purpose

Crohn’s disease poses difficult choices in which the most appropriate treatment option is not always obvious. When this state of uncertainty exists, patients’ preferences should have an increasingly important part of clinical decision making. The purpose of this study was to compare patients’ preferences for surgical intervention in Crohn’s disease with the preferences of surgeons and gastroenterologists.

Methods

Outpatients with Crohn’s disease were interviewed to quantify their preferences for six scenarios by using the prospective preference measure. An identical questionnaire was mailed to all Australian and New Zealand colorectal surgeons and a random sample of 300 Australian gastroenterologists.

Results

Forty-one of 123 patients with Crohn’s disease (33 percent), 92 of 127 colorectal surgeons (72 percent), and 74 of 272 gastroenterologists (27 percent) participated. There were significant differences between patients and gastroenterologists for three of six scenarios and between surgeons and gastroenterologists in four of six scenarios. Seventy-six percent of gastroenterologists were willing to gamble to avoid an ileocolic resection compared with 37 percent of surgeons (chi-squared = 25.44; P < 0.0001) and 39 percent of patients (chi-squared = 15.44; P < 0.001).

Conclusions

Patients and clinicians were able to trade and gamble life expectancy as a measure of preference for varying hypothetical surgical treatments, even though these treatment options impacted on quality of life rather than survival. Patients’ preferences did not align with clinicians. For most scenarios, colorectal surgeons’ preferences were significantly different to those of gastroenterologists.
Literature
1.
go back to reference Solem, CA, Loftus, EV 2004Management of refractory inflammatory bowel diseaseGastroenterol Clin North Am33319324PubMedCrossRef Solem, CA, Loftus, EV 2004Management of refractory inflammatory bowel diseaseGastroenterol Clin North Am33319324PubMedCrossRef
2.
go back to reference Lofberg, R 2003Review article: medical treatment of mild to moderately active Crohn’s diseaseAliment Pharmacol Ther171822PubMedCrossRef Lofberg, R 2003Review article: medical treatment of mild to moderately active Crohn’s diseaseAliment Pharmacol Ther171822PubMedCrossRef
3.
go back to reference Warman, J, Korelitz, B, Fleisher, M, Janardhanam, R 2003Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn’s disease and ulcerative colitisJ Clin Gastroenterol37220225PubMedCrossRef Warman, J, Korelitz, B, Fleisher, M, Janardhanam, R 2003Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn’s disease and ulcerative colitisJ Clin Gastroenterol37220225PubMedCrossRef
4.
5.
go back to reference Blomqvist, P, Feltelius, N, Lofberg, R, Ekbom, A 2001A 10-year survey of inflammatory bowel diseases-drug therapy, costs and adverse reactionsAliment Pharmacol Ther15475481PubMedCrossRef Blomqvist, P, Feltelius, N, Lofberg, R, Ekbom, A 2001A 10-year survey of inflammatory bowel diseases-drug therapy, costs and adverse reactionsAliment Pharmacol Ther15475481PubMedCrossRef
6.
go back to reference Sandborn W, Sutherland L, Pearson D, et al. Azathioprine or 6-mercaptopurine for inducing remission of Crohn’s disease. Cochrane database of Systematic Reviews. Edition 2; www.thecochranelibrary.com. Accessed 23 August 2005 Sandborn W, Sutherland L, Pearson D, et al. Azathioprine or 6-mercaptopurine for inducing remission of Crohn’s disease. Cochrane database of Systematic Reviews. Edition 2; www.​thecochranelibra​ry.​com. Accessed 23 August 2005
7.
go back to reference Stuck, A, Minder, C, Frey, F 1989Risk of infectious complications in patients taking glucocorticosteroidsRev Infect Dis11954963PubMed Stuck, A, Minder, C, Frey, F 1989Risk of infectious complications in patients taking glucocorticosteroidsRev Infect Dis11954963PubMed
8.
go back to reference Rutgeerts, P, Assche, G, Vermeire, S 2004Optimizing anti-TNF treatment in inflammatory bowel diseaseGastroenterology12615931610PubMedCrossRef Rutgeerts, P, Assche, G, Vermeire, S 2004Optimizing anti-TNF treatment in inflammatory bowel diseaseGastroenterology12615931610PubMedCrossRef
9.
go back to reference Sands, BE, Anderson, FH, Bernstein, CN, et al. 2004Infliximab maintenance therapy for fistulizing Crohn’s diseaseN Engl J Med350876885PubMedCrossRef Sands, BE, Anderson, FH, Bernstein, CN,  et al. 2004Infliximab maintenance therapy for fistulizing Crohn’s diseaseN Engl J Med350876885PubMedCrossRef
10.
go back to reference Sandborn, WJ, Hanauer, SB 2002Infliximab in the treatment of Crohn’s disease: a user’s guide for cliniciansAm J Gastroenterol9729622972PubMedCrossRef Sandborn, WJ, Hanauer, SB 2002Infliximab in the treatment of Crohn’s disease: a user’s guide for cliniciansAm J Gastroenterol9729622972PubMedCrossRef
11.
go back to reference Colombel, J, Loftus, EJ, Tremaine, W, et al. 2004The safety profile of infliximab in patients with Crohn’s disease: the Mayo Clinic experience in 500 patientsGastroenterology1261931PubMedCrossRef Colombel, J, Loftus, EJ, Tremaine, W,  et al. 2004The safety profile of infliximab in patients with Crohn’s disease: the Mayo Clinic experience in 500 patientsGastroenterology1261931PubMedCrossRef
12.
go back to reference Bernell, O, Lapidus, A, Hellers, G 2000Risk factors for surgery and postoperative recurrence in Crohn’s diseaseAnn Surg2313845PubMedCrossRef Bernell, O, Lapidus, A, Hellers, G 2000Risk factors for surgery and postoperative recurrence in Crohn’s diseaseAnn Surg2313845PubMedCrossRef
13.
go back to reference Bernell, O, Lapidus, A, Hellers, G 2001Recurrence after colectomy in Crohn’s colitisDis Colon Rectum44647654PubMedCrossRef Bernell, O, Lapidus, A, Hellers, G 2001Recurrence after colectomy in Crohn’s colitisDis Colon Rectum44647654PubMedCrossRef
14.
go back to reference Thompson-Fawcett, MW, Mortensen, NJ 1998Crohn’s diseasePhillips, RK eds. Colorectal surgery: companion to specialist colorectal surgical practiceWB SaundersLondon179216 Thompson-Fawcett, MW, Mortensen, NJ 1998Crohn’s diseasePhillips, RK eds. Colorectal surgery: companion to specialist colorectal surgical practiceWB SaundersLondon179216
15.
go back to reference Regimbeau, JM, Panis, Y, Pocard, M, et al. 2001Long-term results of ileal pouch-anal anastomosis for colorectal Crohn’s diseaseDis Colon Rectum44769779PubMedCrossRef Regimbeau, JM, Panis, Y, Pocard, M,  et al. 2001Long-term results of ileal pouch-anal anastomosis for colorectal Crohn’s diseaseDis Colon Rectum44769779PubMedCrossRef
16.
go back to reference Salkeld, G, Solomon, MJ 2003An economic perspective on evidence-based patient choice in surgeryANZ J Surg73427430PubMedCrossRef Salkeld, G, Solomon, MJ 2003An economic perspective on evidence-based patient choice in surgeryANZ J Surg73427430PubMedCrossRef
17.
go back to reference Solomon, MJ, Pager, CK, Keshava, A, et al. 2003What do patients want? Patient preferences and surrogate decision making in the treatment of colorectal cancerDis Colon Rectum4613511357PubMedCrossRef Solomon, MJ, Pager, CK, Keshava, A,  et al. 2003What do patients want? Patient preferences and surrogate decision making in the treatment of colorectal cancerDis Colon Rectum4613511357PubMedCrossRef
18.
go back to reference Suarez-Almazor, ME, Conner-Spady, B, Kendall, CJ, Russell, AS, Skeith, K 2001Lack of congruence in the ratings of patients’ health status by patients and their physiciansMed Decis Making21113121PubMedCrossRef Suarez-Almazor, ME, Conner-Spady, B, Kendall, CJ, Russell, AS, Skeith, K 2001Lack of congruence in the ratings of patients’ health status by patients and their physiciansMed Decis Making21113121PubMedCrossRef
19.
go back to reference Bruera, E, Willey, JS, Palmer, JL, Rosales, M 2002Treatment decisions for breast carcinoma - patient preferences and physician perceptionsCancer9420762080PubMedCrossRef Bruera, E, Willey, JS, Palmer, JL, Rosales, M 2002Treatment decisions for breast carcinoma - patient preferences and physician perceptionsCancer9420762080PubMedCrossRef
20.
go back to reference Butow, PN, Maclean, M, Dunn, SM 1997The dynamics of change: cancer patients’ preferences for information, involvement and supportAnn Oncol8857863PubMedCrossRef Butow, PN, Maclean, M, Dunn, SM 1997The dynamics of change: cancer patients’ preferences for information, involvement and supportAnn Oncol8857863PubMedCrossRef
21.
go back to reference Stiggelbout, AM, Kiebert, GM 1997A role for the sick role. Patient preferences regarding information and participation in clinical decision-makingCMAJ157383389PubMed Stiggelbout, AM, Kiebert, GM 1997A role for the sick role. Patient preferences regarding information and participation in clinical decision-makingCMAJ157383389PubMed
22.
go back to reference Protheroe, J, Fahey, T, Montgomery, AA, Peters, TJ 2000The impact of patients’ preferences on the treatment of atrial fibrillation: observational study of patient based decision analysisBMJ32013801384PubMedCrossRef Protheroe, J, Fahey, T, Montgomery, AA, Peters, TJ 2000The impact of patients’ preferences on the treatment of atrial fibrillation: observational study of patient based decision analysisBMJ32013801384PubMedCrossRef
23.
go back to reference Ramfelt, E, Langius, A, Bjorvell, H, Nordstrom, G 2000Treatment decision-making and its relation to the sense of coherence and the meaning of the disease in a group of patients with colorectal cancerEur J Cancer Care (Engl)9158166CrossRef Ramfelt, E, Langius, A, Bjorvell, H, Nordstrom, G 2000Treatment decision-making and its relation to the sense of coherence and the meaning of the disease in a group of patients with colorectal cancerEur J Cancer Care (Engl)9158166CrossRef
24.
go back to reference Henman, MJ, Butow, PN, Brown, RF 2002Lay constructions of decision-making in cancerPsychooncology11295306PubMedCrossRef Henman, MJ, Butow, PN, Brown, RF 2002Lay constructions of decision-making in cancerPsychooncology11295306PubMedCrossRef
25.
go back to reference Kennedy, E, Urbach, D, Krahn, M, et al. 2004Azathioprine or ileocolic resection for steroid-dependent terminal ileal Crohn’s disease? A Markov analysisDis Colon Rectum4721202130PubMedCrossRef Kennedy, E, Urbach, D, Krahn, M,  et al. 2004Azathioprine or ileocolic resection for steroid-dependent terminal ileal Crohn’s disease? A Markov analysisDis Colon Rectum4721202130PubMedCrossRef
26.
go back to reference Sonnenberg, A, Gavin, MW 2000Timing of surgery for enterovesical fistula in Crohn’s disease: decision analysis using a time-dependent compartment modelInflamm Bowel Dis6280285PubMedCrossRef Sonnenberg, A, Gavin, MW 2000Timing of surgery for enterovesical fistula in Crohn’s disease: decision analysis using a time-dependent compartment modelInflamm Bowel Dis6280285PubMedCrossRef
27.
go back to reference Kennedy, ED, Detsky, AS, Llewellyn-Thomas, HA, et al. 2000Can the standard gamble be used to determine utilities for uncertain health states? An example using postoperative maintenance therapy in Crohn’s diseaseMed Decis Making207278PubMedCrossRef Kennedy, ED, Detsky, AS, Llewellyn-Thomas, HA,  et al. 2000Can the standard gamble be used to determine utilities for uncertain health states? An example using postoperative maintenance therapy in Crohn’s diseaseMed Decis Making207278PubMedCrossRef
28.
go back to reference Kennedy ED, To T, Steinhart AH, et al. Is the probability trade off a reliable and valid measure for use in young populations with chronic disease? Annual Meeting of Society for Medical Decision Making. Cincinnati, OH: October 2000 Kennedy ED, To T, Steinhart AH, et al. Is the probability trade off a reliable and valid measure for use in young populations with chronic disease? Annual Meeting of Society for Medical Decision Making. Cincinnati, OH: October 2000
29.
go back to reference McLeod, RS, Baxter, NN 1998Quality of life of patients with inflammatory bowel disease after surgeryWorld J Surg22375381PubMedCrossRef McLeod, RS, Baxter, NN 1998Quality of life of patients with inflammatory bowel disease after surgeryWorld J Surg22375381PubMedCrossRef
30.
go back to reference Stiggelbout, AM, Haes, JC 2001Patient preference for cancer therapy: an overview of measurement approachesJ Clin Oncol19220230PubMed Stiggelbout, AM, Haes, JC 2001Patient preference for cancer therapy: an overview of measurement approachesJ Clin Oncol19220230PubMed
31.
go back to reference Edwards, P, Roberts, I, Clarke, I, et al. 2002Increasing response rates in postal questionnaires: systematic reviewBMJ32411831191PubMedCrossRef Edwards, P, Roberts, I, Clarke, I,  et al. 2002Increasing response rates in postal questionnaires: systematic reviewBMJ32411831191PubMedCrossRef
33.
go back to reference SPSS I. SPSS Base. Chicago, IL: SPSS Inc., 2004;12.0.1 SPSS I. SPSS Base. Chicago, IL: SPSS Inc., 2004;12.0.1
34.
go back to reference Hanauer, S, Feagan, B, Lichtenstein, G, et al. 2002Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trialLancet35915411549PubMedCrossRef Hanauer, S, Feagan, B, Lichtenstein, G,  et al. 2002Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trialLancet35915411549PubMedCrossRef
35.
go back to reference Seiderer, J, Goke, B, Ochsenkuhn, T 2000Safety aspects of infliximab in inflammatory bowel disease patients. A retrospective cohort study in 100 patients of a German University HospitalDigestion7039CrossRef Seiderer, J, Goke, B, Ochsenkuhn, T 2000Safety aspects of infliximab in inflammatory bowel disease patients. A retrospective cohort study in 100 patients of a German University HospitalDigestion7039CrossRef
36.
go back to reference Boyd, NF, Sutherland, HJ, Heasman, KZ, Tricthler, DL, Cummings, BJ 1990Whose utilities for decision analysis?Med Decis Making105867PubMedCrossRef Boyd, NF, Sutherland, HJ, Heasman, KZ, Tricthler, DL, Cummings, BJ 1990Whose utilities for decision analysis?Med Decis Making105867PubMedCrossRef
37.
go back to reference King, JT, Tsevat, J, Roberts, MS 2004Positive association between current health and health values for hypothetical disease statesMed Decis Making24367378PubMedCrossRef King, JT, Tsevat, J, Roberts, MS 2004Positive association between current health and health values for hypothetical disease statesMed Decis Making24367378PubMedCrossRef
38.
go back to reference Hartley, JE, Fazio, VW, Remzi, FH, et al. 2004Analysis of the outcome of ileal pouch-anal anastomosis in patients with Crohn’s diseaseDis Colon Rectum4718051811 Hartley, JE, Fazio, VW, Remzi, FH,  et al. 2004Analysis of the outcome of ileal pouch-anal anastomosis in patients with Crohn’s diseaseDis Colon Rectum4718051811
39.
go back to reference Randolph, A, Zollo, M, Egger, M, et al. 1999Variability in physician opinion on limiting pediatric life supportPediatrics103807808CrossRef Randolph, A, Zollo, M, Egger, M,  et al. 1999Variability in physician opinion on limiting pediatric life supportPediatrics103807808CrossRef
40.
go back to reference Scott, NA, Hughes, LE 1994Timing of ileocolonic resection for symptomatic Crohn’s disease - the patient’s viewGut35656657PubMed Scott, NA, Hughes, LE 1994Timing of ileocolonic resection for symptomatic Crohn’s disease - the patient’s viewGut35656657PubMed
41.
go back to reference Delaney, CP, Kiran, RP, Senagore, AJ, et al. 2003Quality of life improves within 30 days of surgery for Crohn’s diseaseJ Am Coll Surg196714721PubMedCrossRef Delaney, CP, Kiran, RP, Senagore, AJ,  et al. 2003Quality of life improves within 30 days of surgery for Crohn’s diseaseJ Am Coll Surg196714721PubMedCrossRef
42.
go back to reference Chew, SS, Ngo, TQ, Douglas, PR, et al. 2003Cholecystectomy in patients with Crohn’s ileitisDis Colon Rectum4614841488PubMedCrossRef Chew, SS, Ngo, TQ, Douglas, PR,  et al. 2003Cholecystectomy in patients with Crohn’s ileitisDis Colon Rectum4614841488PubMedCrossRef
43.
go back to reference Junghans, C, Feder, G, Hemingway, H, Timmis, A, Jones, M 2005Recruiting patients to medical research: double blind randomised trial of “opt-in” versus “opt-out” strategiesBMJ331940944PubMedCrossRef Junghans, C, Feder, G, Hemingway, H, Timmis, A, Jones, M 2005Recruiting patients to medical research: double blind randomised trial of “opt-in” versus “opt-out” strategiesBMJ331940944PubMedCrossRef
44.
go back to reference Stiggelbout, AM, Kiebert, GM, Kievit, J, et al. 1994Utility assessment in cancer patients: adjustment of time tradeoff scores for the utility of life years and comparison with standard gamble scoresMed Decis Making148290PubMedCrossRef Stiggelbout, AM, Kiebert, GM, Kievit, J,  et al. 1994Utility assessment in cancer patients: adjustment of time tradeoff scores for the utility of life years and comparison with standard gamble scoresMed Decis Making148290PubMedCrossRef
45.
go back to reference Souchek, J, Stacks, J, Brody, B, et al. 2000A trial for comparing methods for eliciting treatment preferences from men with advanced prostate cancer: results from the initial visitMed Care3810401050PubMedCrossRef Souchek, J, Stacks, J, Brody, B,  et al. 2000A trial for comparing methods for eliciting treatment preferences from men with advanced prostate cancer: results from the initial visitMed Care3810401050PubMedCrossRef
47.
Metadata
Title
Patient Preferences Between Surgical and Medical Treatment in Crohn’s Disease
Authors
Christopher M. Byrne, M.B.B.S., B.Sc.(Med.), M.S., F.R.A.C.S.
Michael J. Solomon, M.B.B.Ch.(Hons.), M.Sc., F.R.A.C.S.
Jane M. Young, M.B.B.S., M.P.H., Ph.D., F.A.F.P.H.M.
Warwick Selby, M.B.B.S., F.R.A.C.P.
James D. Harrison, B.Sc.(Hons.), M.P.H.
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
Diseases of the Colon & Rectum / Issue 5/2007
Print ISSN: 0012-3706
Electronic ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-006-0847-0

Other articles of this Issue 5/2007

Diseases of the Colon & Rectum 5/2007 Go to the issue